Whole Exome Sequencing Market by Product (Systems, Kits, and Services), Technology (Sequencing by Synthesis, ION Semiconductor Sequencing, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research, and Others), and End User (Hospitals, Clinics, Research Centers, Academic & Government Institutes, Pharmaceutical & Biotechnology Companies, and Others) - Global Opportunity Analysis and Industry Forecast, 2019-2026
|
LI_184398
|
Pages: NA
|
Jan 2020 |
2945 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Exome sequencing is a technique for sequencing all of the exome and protein-coding genes in a genome. This technique includes selection of the subset of DNA that encodes proteins or exons, followed by sequencing of the exonic DNA using high-throughput DNA sequencing methods. Exome sequencing is used to identify genetic variants responsible for diseases such as Miller Syndrome and Alzheimers disease.
The global whole exome sequencing market is driven by increase in number of R&D activities to fulfill new scientific applications, high adoption of advanced technologies, rise in awareness about whole exome sequencing technology, and high demand for diagnosis of rare diseases. However, lack of skilled professionals and ethical & legal issues associated with these techniques restrain the market growth. Furthermore, the high demand for personalized medicine and development of new innovative products by key players provide numerous opportunities for market expansion in the near future.
The whole exome sequencing market is segmented on the basis of product, technology, application, end user, and region. Based on product, it is divided into systems, kits, and services. Systems is further divided into Hiseq Series, Miseq, and ION torrent platforms. Hiseq series is further bifurcated into Hiseq 2500 and Hiseq 1500. ION torrent platforms is sub-divided into ION PGM and ION Proton. Kits are further sub-segmented into DNA fragmentation, end repair, A-Tailing, size selection kits, library preparation kits, and target enrichment kits. The services segment is divided into sequencing services and data analysis (bioinformatics) services. Based on technology, the market is categorized into sequencing by synthesis, ION semiconductor sequencing, and others. The application segment includes diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and others. Diagnostics application segment is further sub-segmented into cancer diagnostics, monogenic (Mendelian) disorders, monogenic types of diabetes, and others. On the basis of end user, the market is classified into hospitals, clinics, research centers, academic & government institutes, pharmaceutical & biotechnology companies, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, F. Hoffmann-La Roche AG, Eurofins Scientific Group, GENEWIZ, Inc., Knome, Inc., Macrogen, Inc., Ambry Genetics Corp., and Beijing Genomics Institute.
Key Benefits
- The study provides an in-depth analysis of the global whole exome sequencing market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Whole Exome Sequencing Market Key Segments:
By Product
- Systems
- Hiseq Series
- Hiseq 2500
- Hiseq 1500
- Miseq
- ION Torrent Platforms
- ION PGM
- ION Proton
- Hiseq Series
- Kits
- DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits
- Library Preparation Kits
- Target Enrichment Kits
- Services
- Sequencing Services
- Data Analysis (Bioinformatics) Services
- Others
By Technology
- Sequencing by Synthesis (SBS)
- ION Semiconductor Sequencing
- Other Technologies
- Sequencing by Ligation (SBL)
- Pyrosequencing
By Application
- Diagnostics
- Cancer Diagnostics
- Monogenic (Mendelian) Disorders
- Monogenic Types of Diabetes
- Others
- Common Diseases and Complex Disorders
- Movement Disorders
- HIV
- Drug Discovery and Development
- Personalized Medicine
- Agriculture & Animal Research
- Others
By End User
- Hospitals
- Clinics
- Research Centers
- Academic & Government Institutes
- Pharmaceutical & Biotechnology Companies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 WHOLE EXOME SEQUENCING MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SYSTEMS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Hiseq Series
4.2.4.1. Market size and forecast
4.2.4.2. Hiseq 2500
4.2.4.2.1. Market size and forecast
4.2.4.3. Hiseq 1500
4.2.4.3.1. Market size and forecast
4.2.5. Miseq
4.2.5.1. Market size and forecast
4.2.6. ION Torrent Platforms
4.2.6.1. Market size and forecast
4.2.6.2. ION PGM
4.2.6.2.1. Market size and forecast
4.2.6.3. ION Proton
4.2.6.3.1. Market size and forecast
4.3. KITS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits
4.3.4.1. Market size and forecast
4.3.5. Library Preparation Kits
4.3.5.1. Market size and forecast
4.3.6. Target Enrichment Kits
4.3.6.1. Market size and forecast
4.4. SERVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Sequencing Services
4.4.4.1. Market size and forecast
4.4.5. Data Analysis (Bioinformatics) Services
4.4.5.1. Market size and forecast
4.4.6. Other Services
4.4.6.1. Market size and forecast
CHAPTER 5 WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SEQUENCING BY SYNTHESIS (SBS)
5.2.1. Market size and forecast
5.3. ION SEMICONDUCTOR SEQUENCING
5.3.1. Market size and forecast
5.4. OTHER TECHNOLOGIES
5.4.1. Market size and forecast
5.4.2. Sequencing by Ligation (SBL)
5.4.2.1. Market size and forecast
5.4.3. Pyrosequencing
5.4.3.1. Market size and forecast
CHAPTER 6 WHOLE EXOME SEQUENCING MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. DIAGNOSTICS
6.2.1. Market size and forecast
6.2.2. Cancer Diagnostics
6.2.2.1. Market size and forecast
6.2.3. Monogenic (Mendelian) Disorders
6.2.3.1. Market size and forecast
6.2.4. Monogenic Types of Diabetes
6.2.4.1. Market size and forecast
6.2.5. Others
6.2.5.1. Market size and forecast
6.2.5.2. Common Diseases and Complex Disorders
6.2.5.2.1. Market size and forecast
6.2.5.3. Movement Disorders
6.2.5.3.1. Market size and forecast
6.2.5.4. HIV
6.2.5.4.1. Market size and forecast
6.3. DRUG DISCOVERY AND DEVELOPMENT
6.3.1. Market size and forecast
6.4. PERSONALIZED MEDICINE
6.4.1. Market size and forecast
6.5. AGRICULTURE & ANIMAL RESEARCH
6.5.1. Market size and forecast
6.6. OTHERS
6.6.1. Market size and forecast
CHAPTER 7 WHOLE EXOME SEQUENCING MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. CLINICAL LABORATORIES
7.3.1. Market size and forecast
7.4. RESEARCH CENTERS
7.4.1. Market size and forecast
7.5. ACADEMIC & GOVERNMENT INSTITUTES
7.5.1. Market size and forecast
7.6. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.6.1. Market size and forecast
7.7. OTHERS
7.7.1. Market size and forecast
CHAPTER 8 WHOLE EXOME SEQUENCING MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.2.4. North America Whole Exome Sequencing Market by Product
8.2.5. North America Whole Exome Sequencing Market by Technology
8.2.6. North America Whole Exome Sequencing Market by Application
8.2.7. North America Whole Exome Sequencing Market by End User
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.3.4. Europe Whole Exome Sequencing Market by Product
8.3.5. Europe Whole Exome Sequencing Market by Technology
8.3.6. Europe Whole Exome Sequencing Market by Application
8.3.7. Europe Whole Exome Sequencing Market by End User
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast
8.4.4. Asia-Pacific Whole Exome Sequencing Market by Product
8.4.5. Asia-Pacific Whole Exome Sequencing Market by Technology
8.4.6. Asia-Pacific Whole Exome Sequencing Market by Application
8.4.7. Asia-Pacific Whole Exome Sequencing Market by End User
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
8.5.4. LAMEA Whole Exome Sequencing Market by Product
8.5.5. LAMEA Whole Exome Sequencing Market by Technology
8.5.6. LAMEA Whole Exome Sequencing Market by Application
8.5.7. LAMEA Whole Exome Sequencing Market by End User
CHAPTER 9 COMPANY PROFILES
9.1. ILLUMINA, INC.
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. THERMO FISHER SCIENTIFIC INC.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. AGILENT TECHNOLOGIES
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. F. HOFFMANN-LA ROCHE AG
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. EUROFINS SCIENTIFIC GROUP
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. GENEWIZ, INC.
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. KNOME, INC.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. MACROGEN, INC.
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. AMBRY GENETICS CORP.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. BEIJING GENOMICS INSTITUTE
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Whole Exome Sequencing Market- Global Opportunity Analysis and Industry Forecast, 2019-2026
- Online Only
-
$3,456$3,041 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,379 - Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,726 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,676 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$7,916 - Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Access
- $0.00
- Published Content E-Access
- Company Profiles E-Access
- Newly Added Content Access
- 10 PDF Downloads
- 5 Excel Data Pack Downloads
- 250 Company Profiles PDF Downloads
-
Start reading
Buy Now
,This title and over 12000 thousand more,available with Avenue Library, Subcription @ $649 T&C*
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.